approval · primary record
CEMIPLIMAB-RWLC
FDA · BLA · 2026-08-31
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-08-31 |
| Brand | LIBTAYO |
| Sponsor | REGENERON PHARMACEUTICALS |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:29.838Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CEMIPLIMAB-RWLC:2026-08-31
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.